Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenated

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 159-163

  Höglund, Johanna ^a   Orlova, Anna ^a   Sundin, Anders ^a   Lundqvist, Hans ^a   Tolmachev, Vladimir ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibody internalization; Cellular processing; Indirect labeling

Indexed keywords

BENZOIC ACID DERIVATIVE; BROMINE; CANCER ANTIBODY; CHLORAMINE DERIVATIVE; CHLORAMINE-T; HALOGEN; MONOCLONAL ANTIBODY; N SUCCINIMIDYL 4 BROMOBENZOATE; N-SUCCINIMIDYL 4-BROMOBENZOATE; RADIOACTIVE IODINE; SUCCINIMIDE DERIVATIVE; TOLUENESULFONIC ACID DERIVATIVE; TOSYLCHLORAMIDE SODIUM;

ARTICLE; CHEMISTRY; COLORECTAL TUMOR; CULTURE MEDIUM; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; PROTEIN BINDING; RADIOIMMUNOTHERAPY; TIME; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BENZOATES; BROMINE RADIOISOTOPES; CELL LINE, TUMOR; CHLORAMINES; COLORECTAL NEOPLASMS; CULTURE MEDIA; HALOGENS; HUMANS; IODINE RADIOISOTOPES; PROTEIN BINDING; RADIOIMMUNOTHERAPY; SUCCINIMIDES; TIME FACTORS; TOSYL COMPOUNDS;

EID: 33750709658     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.159     Document Type: Article

References (28)

1. Lovqvist A, Sundin A, Roberto A, Ahlstrom H, Carlsson J and Lundqvist H: Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine. J Nucl Med 38: 1029-1035, 1997. (Pubitemid 27339606)
2. 76Br-labeled monoclonal anti-CEA antibodies for radioimmuno positron emission tomography. Nucl Med Biol 22: 125-131, 1995.
3. Lovqvist A, Sundin A, Ahlstrom H, Carlsson J and Lundqvist H: Pharmacokinetics and experimental PET imaging of a bromine- 76-labeled monoclonal anti-CEA antibody. J Nucl Med 38: 395-401, 1997. (Pubitemid 27376892)
4. 124I-CDR-grafted humanized A33 monoclonal antibody. J Nucl Med 42: 764-769, 2001.
5. 76Br]bromobenzoate for radioimmuno PET. Nucl Med Biol 27: 837-843, 2000.
6. 76Brbromination of monoclonal antibodies using chloramine-T. Nucl Med Biol 26: 923-929, 1999.
7. 125I]- N-succinimidyl-para-iodobenzoate using Chloramine-T for labeling of proteins. J Radioanalytical Nucl Chem 246: 207-213, 2000.
8. Bolton AE: Radioiodination techniques. Amersham, UK, 1985.
9. Zalutsky MR, Noska MA, Colapinto EV, Garg PK and Bigner DD: Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Res 49: 5543-5549, 1989. (Pubitemid 19256429)
10. Orlova A, Höglund J, Lubberink M, Lebeda O, Gedda L, Lundqvist H, Tolmachev V and Sundin A: Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for the in vivo dosimetry. Cancer Biother Radiopharm 17: 385-396, 2002.
11. 211Atlabeled antibody A33 - a potential therapeutic agent against metastatic colorectal carcinoma. Cancer Biother Radiopharm 20: 514-523, 2005.
12. Garin-Chesa P, Sakamoto J, Welt S, Real FX, Rettig WJ and Old LJ: Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. Int J Oncol 9: 465-471, 1996. (Pubitemid 26323936)
13. Daghighian F, Barendswaard E, Welt S, Humm J, Scott A, Willingham MC, McGuffie E, Old LJ and Larson SM: Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody. J Nucl Med 37: 1052-1057, 1996. (Pubitemid 126447149)
14. Moritz RL, Ritter G, Catimel B, Cohen LS, Welt S, Old LJ, Burgess AW, Nice EC and Simpson RJ: Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. J Chromatogr A 798: 91-101, 1998. (Pubitemid 28144448)
15. Harapanhalli RS, Schafranek W, Ong GL and Mattes MJ: Lysine-directed radioiodination of proteins with a cyanuric chloride derivative of aminofluorescein. Anal Biochem 231: 50-56, 1995.
16. King DJ, Antoniw P, Owens RJ, et al: Preparation and preclinical evaluation of humanised A33 immunoconjugates for radio-immunotherapy. Br J Cancer 72: 1364-1372, 1995. (Pubitemid 26002644)
17. Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, Tu GF, Ji H, Whitehead RH, Groenen LC, Scott AM, Ritter G, Cohen L, Welt S, Old LJ, Nice EC and Burgess AW: The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci USA 94: 469-474, 1997. (Pubitemid 27053657)
18. Koziorowski J, Henssen C and Weinreich R: A new convenient route to radioiodinated N-succinimidyl 3- and 4-iodobenzoate, two reagents for radioiodination of proteins. Appl Radiat Isot 49: 955-959, 1998. (Pubitemid 28264221)
19. 76Br by a low-energy cyclotron. Appl Radiat Isot 49: 1537-1540, 1998.
20. 111in- labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells. Nucl Med Biol 27: 827-835, 2000.
21. Nikula TK, Bocchia M, Curcio MJ, Sgouros G, Ma Y, Finn RD and Scheinberg DA: Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity. Mol Immunol 32: 865-872, 1995.
22. Ong GL and Mattes MJ: Re-evaluation of the concept of functional affinity as applied to bivalent antibody binding to cell surface antigens. Mol Immunol 30: 1455-1462, 1993.
23. Mattes MJ: On the validity of 'functional affinity' determination for antibodies binding to cell surface antigens or other polyvalent antigens. Cancer Res 55: S5733-S5735, 1995.
24. Kaufman EN and Jain RK: Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. Cancer Res 52: 4157-4167, 1992.
25. Kyriakos RJ, Shih LB, Ong GL, Patel K, Goldenberg DM and Mattes MJ: The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res 52: 835-842, 1992.
26. Shih LB, Thorpe SR, Griffiths GL, Diril H, Ong GL, Hansen HJ, Goldenberg DM and Mattes MJ: The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J Nucl Med 35: 899-908, 1994. (Pubitemid 24151232)
27. Mattes MJ, Griffiths GL, Diril H, Goldenberg DM, Ong GL and Shih LB: Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells. Cancer 73: 787-793, 1994. (Pubitemid 24046632)
28. Barendswaard EC, Humm JL, O'Donoghue JA, Sgouros G, Finn RD, Scott AM, Larson SM and Welt S: Relative therapeutic efficacy of 125I- and 131I-labeled monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med 42: 1251-1256, 2001. (Pubitemid 32717846)